Drug Type Small molecule drug |
Synonyms Corvert Injection, Ibutilide, Ibutilide fumarate (USP) + [4] |
Target |
Mechanism Potassium channel blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (28 Dec 1995), |
Regulation- |
Molecular FormulaC24H40N2O7S |
InChIKeyPAXBPNBQGZYWHP-UHFFFAOYSA-N |
CAS Registry122647-32-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00648 | Ibutilide Fumarate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Arrhythmias, Cardiac | CN | 06 Jun 2006 | |
Atrial Fibrillation | US | 28 Dec 1995 | |
Atrial Flutter | US | 28 Dec 1995 |
Not Applicable | 200 | (Ibutilide Arm) | bzrkksiuqt(nmuywevcvz) = vfkishhpyk scxtgeymhs (ourjowbono, rgrsfmgccv - rwnjmhvsps) View more | - | 24 May 2017 | ||
Placebo (Placebo Arm) | bzrkksiuqt(nmuywevcvz) = dxqxdqlpja scxtgeymhs (ourjowbono, rdwarzzcxr - owezwqoecv) View more | ||||||
Phase 4 | 100 | qiyhwmbqxq(wpfakwcapi) = ayjbkvpbxu pwdndtpqow (nrqputiopg ) View more | Positive | 01 Feb 2017 | |||
qiyhwmbqxq(wpfakwcapi) = xzvwihccqk pwdndtpqow (nrqputiopg ) View more | |||||||
Not Applicable | Atrial Fibrillation Maintenance | 200 | vekywddkmo(apycffgnqv) = zuulslxatl rlarslnjdp (lutkgzwphk ) | - | 21 May 2016 | ||
Placebo | vekywddkmo(apycffgnqv) = zmrgnmqcix rlarslnjdp (lutkgzwphk ) |